The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/24629
StudyName: Eligibility Multiple Myeloma NCT00483262
Date of export from the portal: 02.07.2020
Date of Upload / last change: 10.08.2017
License: Creative Commons BY 4.0

----

Description: 
Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00483262
